Skip to content

hGH Fragment 177-191

AOD-9604 Australia

Everything researchers need to know about AOD-9604 — mechanism, published dosing protocols, side effect profiles, reconstitution, and how to source third-party tested AOD-9604 in Australia.

Quick facts

  • Also known as: Fragment 177-191 (hGH Fragment)
  • Form: Lyophilised powder (>99% purity)
  • Variants: 5 mg
  • 🇦🇺 3–5 business days
HPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID AcceptedHPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID AcceptedHPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID Accepted

Overview

What Is AOD-9604?

AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191) with an additional tyrosine residue. It was specifically developed to research the fat-reducing effects of growth hormone without the growth-promoting or diabetogenic effects. It has been granted GRAS status by the FDA for use in food products.

Also known as Fragment 177-191 (hGH Fragment), AOD-9604 is supplied as a lyophilised research peptide for laboratory use only. Research indicates AOD-9604 stimulates lipolysis and inhibits lipogenesis in adipose tissue models. Unlike full-length hGH, it does not affect IGF-1 levels or insulin sensitivity in preclinical studies. Its mechanism involves interaction with the beta-3 adrenergic receptor pathway.

What Is AOD-9604?
AOD-9604 mechanism diagram

Mechanism

How AOD-9604 Works — Research Mechanism

Research indicates AOD-9604 stimulates lipolysis and inhibits lipogenesis in adipose tissue models. Unlike full-length hGH, it does not affect IGF-1 levels or insulin sensitivity in preclinical studies. Its mechanism involves interaction with the beta-3 adrenergic receptor pathway.

  • Modified fragment of human growth hormone (amino acids 177-191)
  • Stimulates lipolysis without IGF-1 elevation
  • Beta-3 adrenergic receptor pathway interaction
  • No growth-promoting or diabetogenic effects of full-length hGH
  • FDA GRAS status for food product research context

Research reference

AOD-9604 Dosage — Published Research Protocols

The following reference points are drawn from published research literature. These figures are provided for research reference only and do not constitute dosing recommendations. AOD-9604 is sold strictly for laboratory research use.

Protocol tierPublished research detail
Research referencePublished literature varies by model and endpoint — consult primary sources for protocol-specific dosing in laboratory settings
Administration routeSubcutaneous injection is most common in published peptide research protocols
FrequencyDosing frequency depends on compound half-life and research design — daily to weekly intervals reported in literature
Available vial sizes5 mg — select based on your laboratory protocol requirements
TitrationMany research protocols start at lower doses and escalate to assess receptor response and tolerability in models

Research use only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.

Safety research

AOD-9604 Side Effects — Research Findings

Side effect profiles documented in published AOD-9604 research depend on dose, route of administration, and model system. The following are commonly reported findings from research literature — not from personal use contexts.

  • Minimal adverse events reported in published lipolysis research
  • Does not affect IGF-1 or insulin sensitivity in preclinical studies
  • Injection site reactions possible with subcutaneous administration
  • Generally well-tolerated at research doses in literature

Handling

Reconstituting AOD-9604

AOD-9604 is supplied as a lyophilised powder and must be reconstituted before use in laboratory protocols. Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials. Inject diluent slowly down the inside wall of the vial — do not shake vigorously.

Bacteriostatic water is available from EvoPeak. Store reconstituted peptide at 2–8°C and lyophilised powder at −20°C.

Shop bacteriostatic water

Australia

How to Get AOD-9604 in Australia

Researchers in Australia can source AOD-9604 through EvoPeak — a local supplier offering third-party tested research compounds with batch-specific COA documentation and domestic shipping.

  1. 1

    Browse AOD-9604 variants (5 mg) on the EvoPeak product page

  2. 2

    Review the certificate of analysis (COA) for HPLC purity and mass spectrometry identity verification

  3. 3

    Select your vial size and add to cart — prices include GST with same-day Australian dispatch

  4. 4

    Receive your order with batch-specific quality documentation for laboratory traceability

Quality Standard

Research compounds need evidence, not guesswork.

Every shopping path leads back to the same core standard: research-use positioning, third-party quality signals, transparent documentation, and careful handling guidance.

HPLC/MS verified

Purity and identity checks support confident compound selection for controlled research.

Endotoxin screened

Quality review extends beyond purity so researchers can evaluate handling risk.

Batch documentation

COA-first product pages keep quality signals close to every purchase decision.

Australia shipped

Local fulfilment keeps delivery predictable for Australian research customers.

FAQ

AOD-9604 — Common Questions

What is AOD-9604?

Modified growth hormone fragment for lipolysis and fat metabolism research. AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191) with an additional tyrosine residue. It was specifically developed to research the fat-reducing effects of growth hormone … It is supplied for laboratory research use only.

What is the AOD-9604 dosage used in research?

Published research uses varying doses depending on the model and endpoint. EvoPeak supplies 5 mg vials. All dosage information is for research reference only and does not constitute recommendations.

What are the side effects of AOD-9604?

Side effect profiles in published research depend on dose, route, and model system. Consult primary literature for compound-specific findings. All information is drawn from research contexts, not personal use.

Can I buy AOD-9604 in Australia?

Yes. EvoPeak supplies research-grade AOD-9604 to Australian researchers with HPLC/MS verification, batch-specific COA documentation, and domestic shipping. Products are for laboratory research use only.

How do I get AOD-9604 in Australia?

Order from the EvoPeak shop page, select your vial size, review the COA, and checkout with local Australian fulfilment.

How do I reconstitute AOD-9604?

AOD-9604 is supplied as lyophilised powder. Reconstitute with bacteriostatic water, inject diluent slowly down the vial wall without shaking, and store at 2–8°C once reconstituted. Bacteriostatic water is available from EvoPeak.

What purity standard does EvoPeak AOD-9604 meet?

Every batch undergoes HPLC purity analysis (targeting >99%), mass spectrometry identity verification, and endotoxin screening. Batch-specific COAs are available on the product page.

Is aod-9604 peptide the same as Fragment 177-191 (hGH Fragment)?

AOD-9604 is also known as Fragment 177-191 (hGH Fragment). Both refer to the same research compound supplied by EvoPeak.

Ready to order AOD-9604?

Third-party HPLC/MS tested with batch-specific COA documentation. Shipped from Australia for laboratory research use only.